Modulation of Ia+ Langerhans cell numbers in vivo by cultured epidermis derived supernatants and by GM‐CSF
- 1 February 1996
- journal article
- Published by Wiley in Experimental Dermatology
- Vol. 5 (1) , 28-37
- https://doi.org/10.1111/j.1600-0625.1996.tb00090.x
Abstract
This paper demonstrates that epidermal cells in culture produce an activity which can increase the frequency of Ia+ epidermal Langerhans cells (LC). This was achieved by treating mice topically with a mixture containing supernatant derived from primary culture of murine epidermis (ES) and a synthetic corticosteroid, triamcinolone acetonide (TAC). The presence of the supernatant in the mixture partially protected the Ia+ LC from depletion by the steroid. The Ia+ LC frequency increasing activity was measured as the difference between the Ia+ LC frequency due to treatment with steroid mixed with supernatant and the Ia+ LC frequency due to treatment with steroid mixed with negative control medium. The mean frequency of Ia+ LC in epidermis treated with TAC mixed with ES was 606(SD 43) cells/mm2, as compared with 486 (SD 68) cells/mm2 in the epidermis treated with TAC mixed with control medium. The activity appeared to be caused by (a) proteinaceous factor(s). A fraction of ES which was retained above a > or = 10 KDa molecular weight cut-off membrane was capable of partially protecting Ia+ LC frequency from TAC depletion. Supernatants from cultured lymph nodes, dermis as well as the squamous cell carcinoma lines T7 and T79, but not the human osteosarcoma cell-line 143B, also contained similar activities. We demonstrate that GM-CSF also increased the number of Ia+ epidermal LC when applied topically to mouse skin in this system. Therefore, using this Ia+ LC frequency modulation system, we propose that GM-CSF is one example of a cytokine which may be involved in the regulation of Ia+ LC numbers in epidermis and that epidermal cells produce factors which can increase the number of Ia+ LC.Keywords
This publication has 33 references indexed in Scilit:
- Immunohistochemical detection of granulocyte/macrophage colony-stimulating factor in Langerhans' cell histiocytosisHistopathology, 1993
- Regulation of leukocyte binding to endothelial tissues by tumor‐derived GM‐CSFInternational Journal of Cancer, 1992
- Interleukin 2 and granulocyte-macrophage colony-stimulating factor induce a perivascular lymphocytic infiltrate in a skin explant modelArchives of Dermatology, 1991
- Indomethacin inhibits the chemical carcinogen benzo(a)pyrene but not dimethylbenz(a)anthracene from altering Langerhans cell distribution and morphologyBritish Journal of Dermatology, 1991
- Purification and identification of murine epidermal dendritic cells: flow cytometry and immunogold labeling.Journal of Histochemistry & Cytochemistry, 1987
- Corticoids and Cultured Human Epidermal Keratinocytes: Specific Intracellular Binding and Clinical EfficacyJournal of Investigative Dermatology, 1981
- Role of antigen-presenting cells in the development and persistence of contact hypersensitivity.The Journal of Experimental Medicine, 1980
- Epidermal Langerhans cells are derived from cells originating in bone marrowNature, 1979
- Mouse epidermal Ia molecules have a bone marrow originNature, 1979
- Expression of ia antigens by murine keratinizing epithelial langerhans cellsImmunogenetics, 1978